Table 5.
Prospective relationship between baseline (2003–2005) RI and the risk of developing obesity at follow-up (2007–2009) among participants who were not obese at baseline in the MrOS Study.
RI | Obesity at follow-up | ||||
---|---|---|---|---|---|
N (%) | Model I | Model II | |||
OR (95% Cl) | p value | OR (95% Cl) | p value | ||
Q1 | 19 (4.7) | 2.06 (1.02, 4.27) | 0.05 | 2.16 (1.06, 4.50) | 0.04 |
Q2 | 30 (5.9) | 2.57 (1.36, 5.09) | 0.005 | 2.61 (1.37, 5.22) | 0.005 |
Q3 | 20 (3.8) | 1.57 (0.79, 3.21) | 0.21 | 1.54 (0.77–3.16) | 0.23 |
Q4 | 14 (2.5) | Ref. | Ref. | ||
Continuousa | 83 (4.1) | 0.86 (0.75–0.99) | 0.03 | 0.85 (0.74, 0.98) | 0.02 |
Abbreviations: CI = confidence interval; MrOS = The Osteoporotic Fractures in Men Study; OR = odds ratio; RI = rhythm index. Model I: adjusted for baseline age and site.
Model II: additionally adjusted for race, education, smoking status, and alcohol use at baseline.
N and % were calculated based on participants in each quartile of the RI and OR and 95% CI were calculated as per 0.1 increase in RI.